Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer

REFERENCES

• Siegel R, Naishadham D, and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63, 11–30, 2013.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer/World Health Organisation: EUCAN. Retrieved from http://eco.iarc.fr/EUCAN/Country.aspx?ISOCountryCd=930
   Google Scholar
• Ye LC, Ren L, Wei Y, Zhu DX, et al. : Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. J Clin Oncol 31, 1931–1938, 2013.
   PubMed Web of Science ®Google Scholar
• Andreyev HJ, Norman AR, Oates J, and Cuningham D: Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34, 503–509, 1998.
   PubMed Web of Science ®Google Scholar
• Van CutsemE, and Arends J: The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9(Suppl 2), S51–S63, 2005.
   Google Scholar
• Attar A, Malka D, Sabaté JM, Bonnetain F, Lecomte T, et al. : Malnutrition is high and underestimated during chemotherapy in gastrointestinal cancer: an AGEO prospective cross-sectional multicenter study. Nutr Cancer 64, 535–542, 2012.
   PubMed Web of Science ®Google Scholar
• Heredia M, Canales S, Sáez C, and Testillano M: The nutritional status of patients with colorectal cancer undergoing chemotherapy. Farm Hosp 32, 35–37, 2008.
   PubMedGoogle Scholar
• Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, et al.: Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results. Clin Nutr 32, 65–72, 2013.
   PubMed Web of Science ®Google Scholar
• Barret M, Malka D, Aparicio T, Dalban C, Locher C, et al.: Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study. Oncology 81, 395–402, 2011.
   PubMed Web of Science ®Google Scholar
• World Health Organisation: Global database on body mass index. . Retrieved from http://apps.who.int/bmi/index.jsp?introPage=intro_3.html
   Google Scholar
• Detsky AS, Laughin JR, Baker JP, Johnston N, Whittaker S, et al.: What is subjective global assessement of nutritional status? J Parenteral Enter Nutr 11, 8–13, 1987.
   PubMed Web of Science ®Google Scholar
• Bauer J, Capra S, and Ferguson M: Use of the scored patient-generated subjective global assessment (pg-sga) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56, 779–785, 2002.
   PubMed Web of Science ®Google Scholar
• Ingenbleek Y, and Carpentier YA: A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res 55, 91–101, 1985.
   PubMed Web of Science ®Google Scholar
• Read JA, Choy ST, Beale PJ, and Clarke SJ: Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer 55, 78–85, 2006.
   PubMed Web of Science ®Google Scholar
• The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group: Perioperative total parenteral nutrition in surgical patients. N Engl J Med 325, 525–532, 1991.
   PubMed Web of Science ®Google Scholar
• Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, et al.: Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12, 489–495, 2011.
   PubMed Web of Science ®Google Scholar
• Prado CMM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, et al.: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumors of the respiratory and gastrointestinal tracts: a population based study. Lancet Oncol 9, 629–635, 2008.
   PubMed Web of Science ®Google Scholar
• Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, et al. : Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15, 2920–2926, 2008.
   Web of Science ®Google Scholar
• Antoun S, Baracos VE, Birdsell L, Escudier B, and Sawyer MB: Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol 21, 1594–1598, 2010.
   PubMed Web of Science ®Google Scholar
• Huillard O, Mir O, Peyromaure M, Tlemsani C, Giroux J, et al.: Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients. Br J Cancer 108, 1034–1041, 2013.
   PubMed Web of Science ®Google Scholar
• Mir O, Coriat R, Blanchet B, Durand JP, Boudou-Rouquette P, et al.: Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma. PLoS One 7(5), e37563, 2012
   PubMed Web of Science ®Google Scholar
• Massicotte MH, Borget I, Broutin S, Baracos VE, Leboulleux S, et al.: Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study. J Clin Endocrinol Metab 98, 2401–2408, 2013.
   PubMed Web of Science ®Google Scholar
• Lieffers JR, Bathe OF, Fassbender K, Winget M, and Baracos VE: Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107, 931–936, 2012.
   PubMed Web of Science ®Google Scholar
• Prado CM, Baracos VE, McCargar LJ, Mourtzakis M, Mulder KE, et al.: Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13, 3264–3268, 2007.
   PubMed Web of Science ®Google Scholar
• Van Vledder M, Levolger S, Ayez N, Verhoef C, Tran TC. et al. : Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 99, 550–557, 2012.
   PubMed Web of Science ®Google Scholar
• Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, et al.: Prognostic effect ofweight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69, 491–497, 1980.
   PubMed Web of Science ®Google Scholar
• Thésaurus National de Cancérologie Digestive. . Retrieved from http://www.tncd.org/
   Google Scholar
• Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, et al.: A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metabol 33, 997–1006, 2008.
   PubMed Web of Science ®Google Scholar
• Shen W, Punyanitya M, Wang ZM, Gallagher D, St-Onge MP, et al.: Total body skeletal muscle and adipose tissue volume estimation from a single abdominal cross-sectional image. J Appl Physiol 97, 2333–2338, 2004.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute Common Toxicity Triteria CTC Version 4.0. . Retrieved from http://www.acrin.org/Portals/0/Administration/ Regulatory/CTCAE_4.02_2009-09-15_QuickReference_5×7.pdf
   Google Scholar
• Burden ST, Hill J, Shaffer JL, and Todd C: Nutritional status of preoperative colorectal cancer patients. J Hum Nutr Diet 23, 402–407, 2010.
   PubMed Web of Science ®Google Scholar
• Larsson SC, and Wolk A: Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 86, 556–565, 2007.
   PubMed Web of Science ®Google Scholar
• Gusella M, Toso S, Ferrazzi E, Ferrari M, and Padrini R: Relationships between body composition parameters and fluorouracil pharmacokinetics. Br J Clin Pharmacol 54, 131–139, 2002.
   PubMed Web of Science ®Google Scholar
• Peng PD, van Vledder MG, Tsai S, de Jong MC, Makary M, et al.: Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford) 13, 439–446, 2011.
   PubMed Web of Science ®Google Scholar